Voloridge Investment Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-181,571
| Closed | -$20.7M | – | 1194 |
|
|
2025
Q1 | $20.7M | Sell |
181,571
-290,052
| -62% | -$33.1M | 0.08% | 345 |
|
|
2024
Q4 | $23.8M | Sell |
471,623
-150,548
| -24% | -$7.59M | 0.08% | 304 |
|
|
2024
Q3 | $28.8M | Sell |
622,171
-147,243
| -19% | -$6.81M | 0.1% | 289 |
|
|
2024
Q2 | $25M | Sell |
769,414
-263,811
| -26% | -$8.57M | 0.09% | 300 |
|
|
2024
Q1 | $26M | Buy |
1,033,225
+485,928
| +89% | +$12.2M | 0.1% | 267 |
|
|
2023
Q4 | $17.8M | Buy |
547,297
+113,273
| +26% | +$3.68M | 0.07% | 351 |
|
|
2023
Q3 | $11.8M | Buy |
434,024
+398,787
| +1,132% | +$10.9M | 0.06% | 418 |
|
|
2023
Q2 | $784K | Sell |
35,237
-29,143
| -45% | -$648K | ﹤0.01% | 1162 |
|
|
2023
Q1 | $1.39M | Sell |
64,380
-1,951
| -3% | -$42.3K | 0.01% | 1061 |
|
|
2022
Q4 | $1.35M | Sell |
66,331
-175,642
| -73% | -$3.57M | 0.01% | 1066 |
|
|
2022
Q3 | $6.2M | Sell |
241,973
-70,870
| -23% | -$1.82M | 0.03% | 578 |
|
|
2022
Q2 | $7.44M | Sell |
312,843
-73,406
| -19% | -$1.75M | 0.04% | 544 |
|
|
2022
Q1 | $8.7M | Buy |
386,249
+318,425
| +469% | +$7.17M | 0.05% | 450 |
|
|
2021
Q4 | $1.34M | Buy |
+67,824
| New | +$1.34M | 0.01% | 1186 |
|
|
2021
Q2 | – | Sell |
-64,270
| Closed | -$1.53M | – | 1626 |
|
|
2021
Q1 | $1.53M | Sell |
64,270
-169,135
| -72% | -$4.02M | 0.01% | 903 |
|
|
2020
Q4 | $6.11M | Sell |
233,405
-119,498
| -34% | -$3.13M | 0.05% | 402 |
|
|
2020
Q3 | $6.14M | Buy |
352,903
+211,385
| +149% | +$3.68M | 0.05% | 389 |
|
|
2020
Q2 | $2.38M | Buy |
141,518
+17,197
| +14% | +$289K | 0.03% | 559 |
|
|
2020
Q1 | $1.48M | Sell |
124,321
-12,903
| -9% | -$153K | 0.04% | 425 |
|
|
2019
Q4 | $1.66M | Buy |
137,224
+101,284
| +282% | +$1.23M | 0.03% | 531 |
|
|
2019
Q3 | $508K | Buy |
+35,940
| New | +$508K | 0.01% | 805 |
|